granisetron oral
Selected indexed studies
- Transdermal versus oral granisetron in controlling chemotherapy-induced nausea and vomiting: a meta-analysis. (Support Care Cancer, 2020) [PMID:32623521]
- Comparative efficacy of oral and intravenous granisetron for the prevention of acute chemotherapy-induced emesis. (Clin Ther, 1996) [PMID:8879888]
- Transdermal granisetron. (Drugs, 2009) [PMID:19943709]
_Worker-drafted node — pending editorial review._
Connections
granisetron oral is a side effect of
Sources
- The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. (2015) pubmed
- Transdermal granisetron. (2009) pubmed
- Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) - is there still a role after comparison with palonosetron? (2017) pubmed
- Transdermal versus oral granisetron in controlling chemotherapy-induced nausea and vomiting: a meta-analysis. (2020) pubmed
- Comparative efficacy of oral and intravenous granisetron for the prevention of acute chemotherapy-induced emesis. (1996) pubmed
- Oral granisetron revisited. (2002) pubmed
- Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis. (2024) pubmed
- About the antiemetic effectivity of granisetron in chemotherapy-induced acute emesis: a comparison of results with intravenous and oral dosing. (1999) pubmed
- Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy. (1995) pubmed
- Oral granisetron for strabismus surgery in children. (1999) pubmed